DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine

[Image: see text] Biomarker-driven drug selection plays a central role in cancer drug discovery and development, and in diagnostic strategies to improve the use of traditional chemotherapeutic drugs. DNA-modifying anticancer drugs are still used as first line medication, but drawbacks such as resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Stornetta, Alessia, Zimmermann, Maike, Cimino, George D., Henderson, Paul T., Sturla, Shana J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2016
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379252/
https://www.ncbi.nlm.nih.gov/pubmed/27936622
http://dx.doi.org/10.1021/acs.chemrestox.6b00380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379252/
https://www.ncbi.nlm.nih.gov/pubmed/27936622
http://dx.doi.org/10.1021/acs.chemrestox.6b00380

Ejemplares similares